Overview
Isolated lissencephaly type 1 without known genetic defects is a rare brain malformation disorder characterized by lissencephaly (smooth brain), in which the normal folds and grooves (gyri and sulci) of the cerebral cortex fail to develop properly during fetal life. This condition falls under the classical lissencephaly (type 1) spectrum but is distinguished by the absence of an identifiable genetic cause through currently available testing methods. The brain surface appears abnormally smooth, ranging from complete absence of gyri (agyria) to reduced and broadened gyri (pachygyria), with a characteristically thickened cortex composed of four abnormal layers rather than the normal six. The condition primarily affects the central nervous system and manifests in early life with severe developmental delay, intellectual disability, seizures (often infantile spasms that may evolve into other seizure types), feeding difficulties, and hypotonia (reduced muscle tone) that may later progress to spasticity. Microcephaly (abnormally small head) may be present or develop postnatally. Affected children typically have profound psychomotor impairment and may have limited or absent speech development. The severity of symptoms generally correlates with the degree of cortical malformation visible on brain MRI. There is currently no cure or disease-modifying treatment for this condition. Management is supportive and symptomatic, focusing on seizure control with antiepileptic medications, nutritional support (which may require gastrostomy tube placement), physical and occupational therapy, and management of respiratory complications. A multidisciplinary approach involving neurologists, developmental pediatricians, and rehabilitation specialists is essential. Prognosis varies but is generally guarded, with many patients experiencing refractory epilepsy and significant lifelong disability.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Isolated lissencephaly type 1 without known genetic defects.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Isolated lissencephaly type 1 without known genetic defects at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Isolated lissencephaly type 1 without known genetic defects.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Isolated lissencephaly type 1 without known genetic defects.
Community
No community posts yet. Be the first to share your experience with Isolated lissencephaly type 1 without known genetic defects.
Start the conversation →Latest news about Isolated lissencephaly type 1 without known genetic defects
No recent news articles for Isolated lissencephaly type 1 without known genetic defects.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Isolated lissencephaly type 1 without known genetic defects
What is Isolated lissencephaly type 1 without known genetic defects?
Isolated lissencephaly type 1 without known genetic defects is a rare brain malformation disorder characterized by lissencephaly (smooth brain), in which the normal folds and grooves (gyri and sulci) of the cerebral cortex fail to develop properly during fetal life. This condition falls under the classical lissencephaly (type 1) spectrum but is distinguished by the absence of an identifiable genetic cause through currently available testing methods. The brain surface appears abnormally smooth, ranging from complete absence of gyri (agyria) to reduced and broadened gyri (pachygyria), with a cha
How is Isolated lissencephaly type 1 without known genetic defects inherited?
Isolated lissencephaly type 1 without known genetic defects follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Isolated lissencephaly type 1 without known genetic defects typically begin?
Typical onset of Isolated lissencephaly type 1 without known genetic defects is neonatal. Age of onset can vary across affected individuals.